Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the ...

Prostate cancer has distinct genetic properties in different groups of men that could be targeted to improve patient outcomes, new research suggests.

An AI-powered blood test for detecting 12 common cancers has been awarded government funding for further clinical trials.

A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

The test, developed by a team at the University of Southampton, uses AI to analyse blood samples for tiny fragments of ...

The breakthrough blood test uses AI to detect the 12 most lethal and common cancers from an mRNA signature which shows if ...

Research suggests the test, known as miONCO-Dx, can detect 12 cancers at an early stage with 99% accuracy. However, a larger ...

Early detection of colon cancer can prevent a majority of deaths, possibly as much as nine in 10 of them. Yet only about 69% ...

Scientists could reshape cancer treatment by helping powerful drugs work better in the body by exploiting a surface protein called CD36 that helps pull substances into cells. This dramatically ...

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...